Predictive Biomarkers for Immune Checkpoint Inhibitors in Metastatic Breast Cancer.
Cancer Medicine
Sivapiragasam, Abirami A; Ashok Kumar, Prashanth P; Sokol, Ethan S ES; Albacker, Lee A LA; Killian, Jonathan K JK; Ramkissoon, Shakti H SH; Huang, Richard S P RSP; Severson, Eric A EA; Brown, Charlotte A CA; Danziger, Natalie N; McGregor, Kimberly K; Ross, Jeffrey S JS
REVEL and BayesDel outperform other in silico meta-predictors for clinical variant classification.
Scientific Reports
Tian, Yuan Y; Pesaran, Tina T; Chamberlin, Adam A; Fenwick, R Bryn RB; Li, Shuwei S; Gau, Chia-Ling CL; Chao, Elizabeth C EC; Lu, Hsiao-Mei HM; Black, Mary Helen MH; Qian, Dajun D
Pembrolizumab for metastatic adrenocortical carcinoma with high mutational burden: Two case reports.
Medicine
Mota, Jose Mauricio JM; Sousa, Luana Guimarães LG; Braghiroli, Maria Ignez MI; Siqueira, Luiz Tenório LT; Neto, João Evangelista Bezerra JEB; Chapchap, Paulo P; Hoff, Ana A de Oliveira AAO; Hoff, Paulo M PM
Comprehensive Genomic Profiling of Hodgkin Lymphoma Reveals Recurrently Mutated Genes and Increased Mutation Burden.
The Oncologist
Liang, Winnie S WS; Vergilio, Jo-Anne JA; Salhia, Bodour B; Huang, Helen J HJ; Oki, Yasuhiro Y; Garrido-Laguna, Ignacio I; Park, Haeseong H; Westin, Jason R JR; Meric-Bernstam, Funda F; Fabrizio, David D; Miller, Vincent A VA; Stephens, Philip J PJ; Fanale, Michelle A MA; Ross, Jeffrey S JS; Janku, Filip F
Personalized Medicine in the Oncology Clinic: Implementation and Outcomes of the Johns Hopkins Molecular Tumor Board.
Jco Precision Oncology
Dalton, W Brian WB; Forde, Patrick M PM; Kang, Hyunseok H; Connolly, Roisin M RM; Stearns, Vered V; Gocke, Christopher D CD; Eshleman, James R JR; Axilbund, Jennifer J; Petry, Dana D; Geoghegan, Cindy C; Wolff, Antonio C AC; Loeb, David M DM; Pratilas, Christine A CA; Meyer, Christian F CF; Christenson, Eric S ES; Slater, Shannon A SA; Ensminger, Jennifer J; Parsons, Heather A HA; Park, Ben H BH; Lauring, Josh J
Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.
Genetics In Medicine : Official Journal Of The American College Of Medical Genetics
Nykamp, Keith K; Anderson, Michael M; Powers, Martin M; Garcia, John J; Herrera, Blanca B; Ho, Yuan-Yuan YY; Kobayashi, Yuya Y; Patil, Nila N; Thusberg, Janita J; Westbrook, Marjorie M; , ; Topper, Scott S
Implementation of next generation sequencing into pediatric hematology-oncology practice: moving beyond actionable alterations.
Genome Medicine
Oberg, Jennifer A JA; Glade Bender, Julia L JL; Sulis, Maria Luisa ML; Pendrick, Danielle D; Sireci, Anthony N AN; Hsiao, Susan J SJ; Turk, Andrew T AT; Dela Cruz, Filemon S FS; Hibshoosh, Hanina H; Remotti, Helen H; Zylber, Rebecca J RJ; Pang, Jiuhong J; Diolaiti, Daniel D; Koval, Carrie C; Andrews, Stuart J SJ; Garvin, James H JH; Yamashiro, Darrell J DJ; Chung, Wendy K WK; Emerson, Stephen G SG; Nagy, Peter L PL; Mansukhani, Mahesh M MM; Kung, Andrew L AL
Presence of both alterations in FGFR/FGF and PI3K/AKT/mTOR confer improved outcomes for patients with metastatic breast cancer treated with PI3K/AKT/mTOR inhibitors.
Oncoscience
Wheler, Jennifer J JJ; Atkins, Johnique T JT; Janku, Filip F; Moulder, Stacy L SL; Stephens, Philip J PJ; Yelensky, Roman R; Valero, Vicente V; Miller, Vincent V; Kurzrock, Razelle R; Meric-Bernstam, Funda F
Oncogenic mutation profiling in new lung cancer and mesothelioma cell lines.
Oncotargets And Therapy
Lam, David Cl DC; Luo, Susan Y SY; Deng, Wen W; Kwan, Johnny Sh JSh; Rodriguez-Canales, Jaime J; Cheung, Annie Lm AL; Cheng, Grace Hw GH; Lin, Chi-Ho CH; Wistuba, Ignacio I II; Sham, Pak C PC; Wan, Thomas Sk TS; Tsao, Sai-Wah SW
Publication Date: 2015
Variant appearance in text: ATM: R189K; rs79075295
Mutational landscape of candidate genes in familial prostate cancer.
The Prostate
Johnson, Anna M AM; Zuhlke, Kimberly A KA; Plotts, Chris C; McDonnell, Shannon K SK; Middha, Sumit S; Riska, Shaun M SM; Schaid, Daniel J DJ; Thibodeau, Stephen N SN; Douglas, Julie A JA; Cooney, Kathleen A KA